Retinal Detachment Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The market is segmented by Product (Instruments, Consumables, and Accessories), by Treatment Type, by End-User, and by Geography.

Market Snapshot

Retinal Detachment Treatment Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 3.3 %
Retinal Detachment Treatment Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Retinal Detachment Treatment market is projected to grow with a CAGR of nearly 3.3% over the forecast period. The major factor attributing to the growth of the market is the increase in the geriatric population and the increasing incidence of diabetic retinopathy and other eye disorders. According to Suresh K Pandey and Vidushi Sharma in their article for the Indian Journal of Ophthalmology, India is deemed as the world's capital of diabetes. The diabetic population in the country is close to hitting the alarming mark of 69.9 million by 2025 and 80 million by 2030. The overall population affected by diabetes-related retinal disease is expected to cross the number of 592 million by 2025, and currently affecting nearly 18% of the diabetic population in India. As per the statistics, the increasing patient pool increases market growth. However, the high cost of the procedures is the major drawback of market growth.

Scope of the Report

As per the scope of the report, retinal detachment is caused when tissue at the back of the eye pulls away from a layer of blood vessels that provide necessary oxygen and nourishment. This report is segmented by Product, by Treatment Type, by End-User and by Geography.

By Product
Consumables and Accessories
By Treatment Type
Pneumatic Retinopexy
Scleral Buckle Surgery
By End-User
Hospitals and Clinics
Specialty Clinics
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Vitrectomy is the fastest growing segment in the market studied

Vitrectomy is a surgical procedure undertaken by a specialist where the vitreous humor gel that fills the eye cavity is removed to provide better access to the retina. This allows for a variety of repairs, including the removal of scar tissue, laser repair of retinal detachments and treatment of macular holes. Once the surgery is complete, saline, a gas bubble or silicone oil may be injected into the vitreous gel to help hold the retina in position. Vitrectomy is an increasingly used treatment for retinal detachment.

The major factors driving the growth of the segment include rising incidence of diabetic retinopathy and other eye disorders. Furthermore increasing geriatric population is also a driving factor. The elderly people are more prone to eye disorders. According to Riccardo Cheloni, Stefano A Gandolfi, in an article of 2019 BMJ Open, there were around 422 million diabetic retinopathy cases globally and estimated to rise to 629 million by 2045. As the prevalence of these diseases increase the segment growth also increases.

Retinal Detachment Treatment Market Share

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the presence of key players, high prevalence of diabetes in the region, increasing geriatric population, and an established healthcare infrastructure. Furthermore, beneficial government initiatives and increase in number of research partnerships are some of the drivers expected to increase the market growth.

In this region, the United States holds the maximum share due to supportive healthcare policies, high number of patients, and a developed healthcare market. According to the Centers for Disease Control and Prevention, diabetic retinopathy is the most common cause of vision impairment and blindness among working-age adults in the United States. By 2050, the number of Americans with diabetic retinopathy is expected to reach 14.6 million. These statistics state that the region has the maximum number of patients and hence has a greater share of the market.

Retinal Detachment Treatment Market Analysis

Competitive Landscape

The  Retinal Detachment Treatment market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Aspen Surgical, FCI, Inami & CO., Ltd, Rudolf Riester GmbH, Millennium Surgical Corp, Welch Allyn, Inc, Accurate Surgical & Scientific Instruments Corporation, Trufocus Corporation, Keeler Ltd, Gilras.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Geriatric Population

      2. 4.2.2 Increasing Diabetes Retinopathy and Other Eye Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of the Treatment

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Instruments

      2. 5.1.2 Consumables and Accessories

    2. 5.2 By Treatment Type

      1. 5.2.1 Pneumatic Retinopexy

      2. 5.2.2 Scleral Buckle Surgery

      3. 5.2.3 Vitrectomy

      4. 5.2.4 Others

    3. 5.3 By End-User

      1. 5.3.1 Hospitals and Clinics

      2. 5.3.2 Specialty Clinics

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Aspen Surgical

      2. 6.1.2 FCI

      3. 6.1.3 Inami & CO.,Ltd

      4. 6.1.4 Rudolf Riester GmbH

      5. 6.1.5 Millennium Surgical Corp

      6. 6.1.6 Welch Allyn, Inc


      8. 6.1.8 Trufocus Corporation

      9. 6.1.9 Keeler Ltd

      10. 6.1.10 Gilras

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Retinal Detachment Treatment Market market is studied from 2018 - 2026.

The Retinal Detachment Treatment Market is growing at a CAGR of 3.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Aspen Surgical, FCI, Inami & CO.,Ltd, Rudolf Riester GmbH, Millennium Surgical Corp are the major companies operating in Retinal Detachment Treatment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!